Cyril H. Benes
Computational Theory and Mathematics · 2005–2016
A researcher in the Science corpus: 11 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Computational Theory and Mathematics — 12 citations into it
- Statistics and Probability — 5 citations into it
Whom Cyril H. Benes trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Cyril H. Benes overall
Papers from Cyril H. Benes's perspective
Ordered by how strongly the researchers Cyril H. Benes trusts endorse each paper. Same corpus, a different order for every researcher.
- Addendum: Regularization and variable selection via the elastic net
- Random Forests
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- Systematic variation in gene expression patterns in human cancer cell lines (Nature Genetics)
- A direct adaptive method for faster backpropagation learning: the RPROP algorithm
- The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity (Nature)
- BRAF mutation predicts sensitivity to MEK inhibition (Nature)
- Systematic identification of genomic markers of drug sensitivity in cancer cells (Nature)
- PubChem: Integrated Platform of Small Molecules and Biological Activities
- Discovery and saturation analysis of cancer genes across 21 tumor types (Nature)
Their papers
- Systematic identification of genomic markers of drug sensitivity in cancer cells (2012) — 2,417 citations
- Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties (2012) — 475 citations
- Targeting transcription regulation in cancer with a covalent CDK7 inhibitor (2014) — 793 citations
- A Landscape of Pharmacogenomic Interactions in Cancer (2016) — 1,831 citations
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells (2012) — 3,577 citations
- Targeting MYCN in neuroblastoma by BET bromodomain inhibition. (2013) — 628 citations
- Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility (2014) — 887 citations
- Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers (2012) — 1,322 citations
- Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer (2016) — 1,054 citations
- Patient-derived Models of Acquired Resistance Can Identify Effective Drug Combinations for Cancer (2014) — 708 citations
- The C2 Domain of PKCδ Is a Phosphotyrosine Binding Domain (2005) — 222 citations